MettlerToledo
0K10.L
$1 368.65 -3.65%
Exchange: LSE | Sector: Healthcare | Industry: Medical Pharmaceuticals
Q1 2025
Published: May 2, 2025

Earnings Highlights

  • Revenue of $883.74M down 4.6% year-over-year
  • EPS of $7.84 decreased by 5.3% from previous year
  • Gross margin of 57.6%
  • Net income of 163.59M
  • "N/A" - N/A
0K10.L
Company 0K10.L

Executive Summary

Mettler-Toledo International Inc delivered a Q1 2025 performance profile characterized by revenue softness amid a high-margin business framework and robust free cash flow generation. Reported revenue of USD 883.7 million declined 4.6% year over year and 15.4% quarter over quarter, reflecting a softer demand environment and ongoing mix effects within its diversified portfolio of laboratory, industrial, and retail weighing solutions. Despite top-line pressure, gross margins remained resilient at approximately 57.6%, supporting EBITDA of USD 248.3 million (EBITDA margin ~28.1%) and operating income of USD 219.5 million (operating margin ~24.8%). Net income reached USD 163.6 million with EPS of USD 7.84, underscoring continued profitability in a challenging quarter. Notably, the company generated substantial free cash flow of USD 177.2 million and operating cash flow of USD 194.4 million, funding capital expenditures of USD 17.3 million and contributing to a solid cash generation backdrop.

Key Performance Indicators

Revenue
Decreasing
883.74M
QoQ: -15.44% | YoY: -4.56%
Gross Profit
Decreasing
508.69M
57.56% margin
QoQ: -18.10% | YoY: -4.00%
Operating Income
Decreasing
219.54M
QoQ: -34.21% | YoY: -11.87%
Net Income
Decreasing
163.59M
QoQ: -35.16% | YoY: -7.84%
EPS
Decreasing
7.84
QoQ: -34.67% | YoY: -5.31%

Revenue Trend

Margin Analysis

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q3 2025 1,029.70 10.57 +7.9% View
Q2 2025 983.22 9.77 +3.9% View
Q1 2025 883.74 7.84 -4.6% View
Q4 2024 1,045.13 11.96 +11.8% View
Q3 2024 954.54 9.94 +1.3% View